The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice
Gonzalez‐Ericsson, Paula I⋅Stovgaard, Elisabeth S⋅Sua, Luz F⋅Reisenbichler, Emily⋅Kos, Zuzana⋅Carter, Jodi M⋅Michiels, Stefan⋅Le Quesne, John⋅Nielsen, Torsten O⋅Lænkholm, Anne‐Vibeke⋅Fox, Stephen B⋅Adam, Julien⋅Bartlett, John MS⋅Rimm, David L⋅Quinn, Cecily⋅Peeters, Dieter⋅Dieci, Maria V⋅Vincent‐Salomon, Anne⋅Cree, Ian⋅Hida, Akira I⋅Balko, Justin M⋅Haynes, Harry R⋅Frahm, Isabel⋅Acosta‐Haab, Gabriela⋅Balancin, Marcelo⋅Bellolio, Enrique⋅Yang, Wentao⋅Kirtani, Pawan⋅Sugie, Tomoharu⋅Ehinger, Anna⋅Castaneda, Carlos A⋅Kok, Marleen⋅McArthur, Heather⋅Siziopikou, Kalliopi⋅Badve, Sunil⋅Fineberg, Susan⋅Gown, Allen⋅Viale, Giuseppe⋅Schnitt, Stuart J⋅Pruneri, Giancarlo⋅Penault‐Llorca, Frederique⋅Hewitt, Stephen⋅Thompson, E Aubrey⋅Allison, Kimberly H⋅Symmans, William F⋅Bellizzi, Andrew M⋅Brogi, Edi⋅Moore, David A⋅Larsimont, Denis⋅Dillon, Deborah A⋅Lazar, Alexander⋅Lien, Huangchun⋅Goetz, Matthew P⋅Broeckx, Glenn⋅El Bairi, Khalid⋅Harbeck, Nadia⋅Cimino‐Mathews, Ashley⋅Sotiriou, Christos⋅Adams, Sylvia⋅Liu, Shi‐wei⋅Loibl, Sibylle⋅Chen, I‐Chun⋅Lakhani, Sunil R⋅Juco, Jonathan W⋅Denkert, Carsten⋅Blackley, Elizabeth F⋅Demaria, Sandra⋅Leon‐Ferre, Roberto⋅Gluz, Oleg⋅Zardavas, Dimitrios⋅Emancipator, Kenneth⋅Ely, Scott⋅Loi, Sherene⋅Salgado, Roberto and Sanders, Melinda
The Journal of Pathology, vol. 250, (no. 5), pp. 684, April 2020. | Journal Article